I

ImmunoGenesis, Inc.

14 employees

ImmunoGenesis specializes in science-driven immune therapies for tumor treatment.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Diagnostics
Health Care
Therapeutics
Medical
Life Science

Date founded

2019

Funding rounds raised

Total raised

$16M

from 4 investors over 4 rounds

I

ImmunoGenesis, Inc. raised $4.5M on June 27, 2023

Investors: Cancer Focus Fund

I

ImmunoGenesis, Inc. raised undisclosed on December 1, 2020

Investors: Texas HALO Fund

I

ImmunoGenesis, Inc. raised $8M on September 16, 2020

Investors: Juno Capital

I

ImmunoGenesis, Inc. raised $16M on August 24, 2020

Investors: Cancer Prevention and Research Institute of Texas

FAQ